Previous studies have shown that CTSV is primarily expressed in the stromal tissue surrounding PDAC tumor cells, and its elevated expression is associated with poor prognosis in PDAC patients, making it a potential biomarker and treatment target for prognostic assessment [47]. The gene discussed is CTSV; the disease is neoplasm.